This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Darrell S. Rigel, MD
Ronald O. Perelman Department of Dermatology New York University School of Medicine 35 E 35th St, Suite 208 New York, NY 10016

Robert J. Friedman, MD; Alfred W. Kopf, MD
New York

June K. Robinson, MD
Evanston, Ill

Rex A. Amonette, MD
Memphis, Tenn

Arch Dermatol. 1997;133(5):656-658.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Malignant melanoma presents a serious public health problem in the United States. Currently, malignant melanoma is the fifth most common cancer in the United States.¹ In this era of concerns regarding health care expenditures, it has been estimated that more than $1 billion was spent on melanoma treatment in the United States in 1990.²

In the August 1996 issue of the ARCHIVES, Swerlick and Chen³ present a viewpoint that implies that the "perceived" rise in melanoma incidence is caused by dermatologists' efforts in screening and public education. Un . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?